Targeted therapies in second line treatment of metastatic non-small cell lung cancer
Moro-Sibilot, D.; Coudurier, M.
La Revue du Praticien 59(7): 955-956
2009
ISSN/ISBN: 0035-2640 PMID: 19839465 Document Number: 632272
Document emailed within 1 workday
Related Documents
Moro-Sibilot, D.; Coudurier, M. 2009: Second line chemotherapy in metastatic non-small cell lung cancer La Revue du Praticien 59(7): 952-953Acharyya, S.; Sau, S.; Dasgupta, P.; Chakraborty, A.; Gangopadhyay, S. 2012: Skin rash as a surrogate marker of clinical response of targeted therapy using gefitinib in advanced or metastatic non-small-cell lung cancer--a retrospective study Journal of the Indian Medical Association 110(7): 474-6 493
Khuri, F.R. 2002: Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy Oncology 16(6 Suppl 6: 53-62
Lind, J.S.W.; Herder, G.J.M.; Smit, E.F. 2008: New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis Nederlands Tijdschrift Voor Geneeskunde 152(16): 928-932
Ishiura, Y.; Yamamoto, H.; Terasaki, Y.; Ishida, Y.; Tohge, M.; Segawa, M.; Kusajima, Y.; Saitoh, K.; Ishikawa, M.; Hirokami, N.; Kasahara, K.; Fujimura, M. 2011: Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2631-2633
Herbst, R.S. 2002: Targeted therapy in non-small-cell lung cancer Oncology 16(9 Suppl 9: 19-24
Ryo, H.; Toyama, K.; Isobe, K.; Sugino, K.; Sano, G.; Yamada, H.; Hiroi, M.; Hojyo, T.; Kimura, K. 2003: A phase I study of gemcitabine and irinotecan as second line treatment for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 237-242
Nakamura, Y.; Yamamoto, N. 2009: Second-line treatment and targeted therapy of advanced lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 710-716
Wu, G.; Qian, G. 2014: Further intensifying researches on targeted therapy for non-small cell lung cancer Zhonghua Yi Xue Za Zhi 94(30): 2321-2323
Shi, Y.; Sun, Y. 2014: The development trend of targeted therapy in non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 36(7): 481-484
Bilgi, O.; Karagoz, B.; Alacacioglu, A.; Ozgun, A.; Tuncel, T.; Gokhan-Kandemir, E. 2010: Irinotecan and cisplatin vs. cyclophosphamide, doxorubicin, and vincristine as second-line treatment after platinum and etoposide in small-cell lung cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 15(2): 395
Nagai, M.; Oguma, H.; Arai, F.; Watanabe, E.; Nakazawa, M. 2014: Analysis of initial treatment only by linac-based stereotactic radiosurgery for a metastatic brain tumor from non-small cell lung cancer No Shinkei Geka. Neurological Surgery 42(4): 327-334
Shi, Y.; Sun, Y. 2015: Molecular targeted therapy of non-small cell lung cancer in China: the first 10 years Zhonghua Yi Xue Za Zhi 95(8): 564-569
Giannakakis, T.; Kakolyris, S.; Theodoropoulos, E.; Kouroussis, C.; Michailakis, E.; Papadouris, S.; Tsitoura, M.; Kalbakis, K.; Souglakos, J.; Agelaki, S.; Vardakis, N.; Georgoulias, V. 2002: A multicenter phase Ii study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer Anticancer Research 22(6b): 3743-3748
Lin, J.C.; Cheng, J.Y.; Meng, C.L. 1992: An animal model for colon cancer metastases to the lung and establishment of metastatic cancer cell line Journal of the Formosan Medical Association 91(Suppl 1): S34-S38
Muhammet Hacioglu, B.; Kostek, O.; Erdogan, B.; Uzunoglu, S.; Cicin, I. 2017: Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis Journal of Buon: Official Journal of the Balkan Union of Oncology 22(3): 586-591
Aapro, M.S. 1997: Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer Oncology 11(8 Suppl 8: 46-49
Mirski, S.E.; Evans, C.D.; Almquist, K.C.; Slovak, M.L.; Cole, S.P. 1993: Altered topoisomerase Ii alpha in a drug-resistant small cell lung cancer cell line selected in VP-16 Cancer Research 53(20): 4866-4873
Wachters, F.M.; Van Der Graaf, W.T.A.; Groen, H.J.M. 2004: Cardiotoxicity in advanced non-small cell lung cancer patients treated with platinum and non-platinum based combinations as first-line treatment Anticancer Research 24(3b): 2079-2083
Evans, W.K.; Shepherd, F.A.; Feld, R.; Osoba, D.; DeBoer, G. 1986: First-line therapy with VP-16 and cisplatin for small-cell lung cancer Seminars in Oncology 13(3 Suppl 3: 17-23